Novo Nordisk | NVO - Koszty Operacyjne

Cena Akcji
36.83
Dzienna Zmiana
-0.20 -0.54%
Miesięcznie
-7.07%
Rocznie
-52.07%
Q1 Prognozy TE
34.66




Koszty Operacyjne Zmiana Data
ANI Pharmaceuticals USD 217.93M 287.88M 2025-12
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Bausch Health Companies USD 2.08B 113M 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Canopy Growth CAD 87.2M 6.22M 2025-12
Corcept Therapeutics USD 197.64M 219K 2025-12
Drreddys Laboratories INR 72.94B 4.33B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Merck USD 10.16B 558M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Novartis USD 9.8B 61M 2025-12
Novo Nordisk DKK 46.76B 3.99B 2025-12
Novo Nordisk DKK 6.5B 32.8B 2025-06
Pacira USD 193.68M 27.32M 2025-12
Perrigo USD 1.03B 75.3M 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 200.95M 6.51M 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
Zoetis USD 1.55B 3.85B 2025-12